Archive ready

自主回収｜クラス１｜報道発表資料｜厚生労働省

https://www.mhlw.go.jp/stf/newpage_08207.html

April 3, 2026 at 09:30 PM JST•The archive page, viewer, and downloads use this saved version.

April 3, 2026 at 09:30 PM JST·www.mhlw.go.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved page

自主回収｜クラス１｜報道発表資料｜厚生労働省

Open the archived HTML with saved-time metadata attached.

Original URLhttps://www.mhlw.go.jp/stf/newpage_08207.html

StartedApril 3, 2026 at 09:30 PM JST

This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.

About this pageAI generated

This page is a press release from Japan's Ministry of Health, Labour and Welfare regarding a drug recall. Zeria Novo Corporation has initiated a voluntary recall of the pharmaceutical product with the general name "Japanese Pharmacopoeia Nizatidine" and brand name "Acsinon Tablet 75mg." The affected lots include A71, B72, B73, F714-F719, G720, E812-E814, and J825. Released on December 3, 2019, the document provides contact information from relevant divisions within the ministry's Pharmaceutical and Medical Devices Agency.

Screenshot

The full page can be captured up to 15,000px in height so you can review the complete page layout when needed.